regulatory_update

Momence, Illinois – September 08, 2026 -- FutureCeuticals, Inc. and Aura Scientific have settled a patent and trademark dispute over Aura's cognitive-health ingredient "NeuroRush," ending the product and replacing it with a new distribution partnership for FutureCeuticals' whole coffee cherry extract, sold as "CognatiQ" and "NeuroFactor."

Settlement terminates NeuroRush, validates FutureCeuticals' IP portfolio

The resolution confirms the validity of FutureCeuticals' intellectual property in the cognitive health ingredient category, according to J. Randal Wexler, the company's Vice President and General Counsel. Aura's NeuroRush ingredient will be discontinued as part of the agreement.

Dallas – September 08, 2026 -- Cango Inc. (NYSE: CANG) has regained compliance with the New York Stock Exchange's minimum share price requirement, the company said, closing a listing-standards issue that began in March.

NYSE confirms Cango cleared the $1.00 threshold as of August 31, 2026

In a letter dated September 1, 2026, the NYSE notified Cango that its average closing share price over the 30 trading days ended August 31, 2026 exceeded the exchange's US$1.00 minimum under Section 802.01C of the NYSE Listed Company Manual. The exchange confirmed the matter is now closed.

Company had received a deficiency notice on March 10, 2026

The NYSE had flagged Cango after its Class A ordinary shares' 30-trading-day average closing price fell below $1.00, triggering a formal compliance notification.

Berlin – September 07, 2026 -- Hans-Werner Borries, deputy chairman of Germany's Federal Association for the Protection of Critical Infrastructure (BSKI), said security measures at critical infrastructure sites across Germany are currently inadequate to counter a new wave of suspected sabotage attacks on the power grid.

Borries Says Suspected Foreign-State Sabotage Marks Start of Pre-Hybrid Warfare Phase

Speaking on rbb24 Inforadio Thursday, Borries said that as long as even initial suspicion of foreign state-directed sabotage persists, infrastructure operators are operating in a phase of pre-hybrid warfare. He said protecting infrastructure assets is no longer straightforward, forcing companies to reassess whether current investment levels are sufficient.

Tysons Corner, Virginia – September 07, 2026 -- Cellebrite DI Ltd. (Nasdaq: CLBT) said its cloud-based digital evidence management platform, Guardian, has completed an assessment under Australia's Infosec Registered Assessors Program (IRAP) at the PROTECTED classification level, clearing a key hurdle for adoption by Australian law enforcement, defense and national security agencies.

CyberCX, an ASD-approved assessor, conducted the independent review

The evaluation was carried out by CyberCX, an IRAP assessment body accredited by the Australian Signals Directorate (ASD). The certification gives Australian agencies documented, independent evidence that Guardian can handle sensitive digital evidence workloads in the cloud without compromising security.

Dubai, UAE – September 07, 2026 -- XTransfer has secured in-principle approval for a Retail Payment Services Licence from the Central Bank of the UAE, a move that will let the B2B cross-border payment platform serve mainland UAE clients once pre-issuance conditions are met.

Regulator clears path for mainland UAE trade payments

The licence extends XTransfer's regulated payment services into the UAE, positioning the company to support businesses engaged in international trade with compliant, secure cross-border transaction tools once formal issuance is complete.

UAE approval anchors China-Middle East-Africa trade corridor

The UAE serves as a major regional trade and re-export hub connecting Chinese commerce with Africa and other emerging markets. XTransfer said the licence strengthens its capacity to support trade flows between China, the Middle East and Africa with more accessible cross-border payment infrastructure.

Nanjing – September 07, 2026 -- Scage Future (Nasdaq: SCAG) has fallen below two separate Nasdaq minimum listing thresholds, receiving deficiency notices tied to both its total market value of listed securities and its market value of publicly held shares.

Nasdaq flags dual shortfalls in 30-day trading review

The Listing Qualifications Department of The Nasdaq Stock Market sent two notification letters dated August 27, 2026. Based on the 30 consecutive business days from July 16 to August 26, 2026, Scage's Market Value of Listed Securities (MVLS) fell short of the required US$50,000,000 minimum under Rule 5450(b)(2)(A). Nasdaq also noted the company fails the alternative Total Assets and Total Revenue standard under Rule 5450(b)(3)(A). A second letter cited the company's Market Value of Publicly Held Shares (MVPHS) falling below the required US$15,000,000 minimum under Rule 5450(b)(2&3)(C) over the same period.

Austin, Texas – – September 07, 2026 -- The U.S. Bankruptcy Court for the Southern District of Texas has confirmed TPx's Plan of Reorganization, clearing the managed services provider to emerge from Chapter 11 with a lighter debt load and fresh capital access.

Court confirmation sets up new ownership structure for TPx

Under the confirmed Plan, a group of investors comprising TPx's existing lenders and its equity sponsor will become the company's new owners once regulatory approvals and customary closing conditions are satisfied. The group will also provide new financing, leaving TPx well capitalized upon emergence.

Berlin – September 07, 2026 -- Germany's largest pharmaceutical trade association, Pharma Deutschland, has warned that new cost-containment measures under the GKV-BStabG threaten drug supply, innovation, and investment in the country, even as it welcomes a fresh round of government dialogue on AMNOG reform.

Federal Ministry convenes stakeholders for September 3 dialogue

The Federal Ministry of Health has invited industry representatives to an in-depth discussion on Thursday, September 3, 2026, focused on harmonizing Germany's drug pricing and assessment framework. Pharma Deutschland, which represents roughly 400 member companies employing about 80,000 people in Germany, said it backs the continuation of the Pharma- und Medizintechnik Dialog but insists selective bureaucratic fixes cannot offset broader damage from recent legislation.

Berlin – September 07, 2026 -- The German Fire Brigade Association (DFV) has published new technical guidance on grounding live overhead lines in rail zones, following DB InfraGO's decision to revoke existing voluntary agreements with fire departments nationwide.

DB InfraGO Cancels Prior Grounding Agreements With Fire Departments

Previous contractual arrangements allowing fire brigades to perform emergency grounding, known as "Bahnerdung," on Deutsche Bahn AG infrastructure have been withdrawn by the rail operator's emergency management unit. Fire department carriers and DB InfraGO, the infrastructure operator, must now negotiate new agreements based on updated regulations and revised training requirements.

New York – September 07, 2026 -- Bayesian Health has secured a New Technology Add-on Payment (NTAP) from the Centers for Medicare and Medicaid Services, making it the first continuous sepsis monitoring technology to hold both FDA clearance and a dedicated Medicare reimbursement pathway.

The approval, issued under CMS's FY 2027 Inpatient Prospective Payment System Final Rule, takes effect October 1, 2026, and allows hospitals using Bayesian's FDA-cleared sepsis flagging device to bill Medicare an add-on payment of up to $61.84 per eligible inpatient case.